D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
PUT
Adient
ADNT
$1.62B
| $975K | ﹤0.01% |
75,200
+19,600
| +35% | +$343K |
|
2577
Carlyle Secured Lending
CGBD
$710M
| $973K | ﹤0.01% |
+67,167
| New | +$988K |
|
|
USG
2578
DELISTED
Usg
USG
| $973K | ﹤0.01% |
+22,479
| New | +$969K |
|
2579
BWX Technologies
BWXT
$16.2B
| $972K | ﹤0.01% |
19,600
-93,941
| -83% | -$4.44M |
|
2580
PUT
Applied Optoelectronics
AAOI
$7.85B
| $966K | ﹤0.01% |
79,200
-63,000
| -44% | -$950K |
|
2581
ATN International
ATNI
$364M
| $966K | ﹤0.01% |
17,122
-24,108
| -58% | -$1.6M |
|
2582
Supernus Pharmaceuticals
SUPN
$2.73B
| $965K | ﹤0.01% |
27,535
-25,367
| -48% | -$944K |
|
2583
PJT Partners
PJT
$4.36B
| $964K | ﹤0.01% |
23,072
+3,498
| +18% | +$150K |
|
2584
PUT
NovoCure
NVCR
$1.97B
| $963K | ﹤0.01% |
+20,000
| New | +$963K |
|
|
ISEE
2585
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $962K | ﹤0.01% |
682,561
-1,839,434
| -73% | -$2.57M |
|
2586
Arlo Technologies
ARLO
$1.51B
| $958K | ﹤0.01% |
+231,795
| New | +$1.28M |
|
2587
CALL
Vornado Realty Trust
VNO
$7.43B
| $958K | ﹤0.01% |
+14,200
| New | +$952K |
|
2588
Deutsche Bank
DB
$67.9B
| $956K | ﹤0.01% |
117,700
+1,019
| +0.9% | +$8.93K |
|
2589
Merit Medical Systems
MMSI
$4.54B
| $956K | ﹤0.01% |
15,466
+7,145
| +86% | +$405K |
|
2590
PNC Financial Services
PNC
$99.6B
| $954K | ﹤0.01% |
7,780
-44,445
| -85% | -$5.5M |
|
2591
Omega Healthcare
OHI
$15.3B
| $953K | ﹤0.01% |
24,971
-368,425
| -94% | -$13.7M |
|
2592
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.39B
| $950K | ﹤0.01% |
33,912
| – | – |
|
|
MRO
2593
PUT
DELISTED
Marathon Oil Corporation
MRO
| $949K | ﹤0.01% |
56,800
+26,800
| +89% | +$438K |
|
|
SFUN
2594
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $949K | ﹤0.01% |
14,053
-3,953
| -22% | -$302K |
|
|
QTNA
2595
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
| $946K | ﹤0.01% |
38,883
+18,321
| +89% | +$319K |
|
2596
Marten Transport
MRTN
$1.26B
| $942K | ﹤0.01% |
79,239
-100,755
| -56% | -$1.23M |
|
|
APHA
2597
DELISTED
Aphria Inc. Common Shares
APHA
| $940K | ﹤0.01% |
100,700
+44,500
| +79% | +$391K |
|
2598
Safe Bulkers
SB
$766M
| $937K | ﹤0.01% |
641,769
+346,152
| +117% | +$572K |
|
|
TRST
2599
Trustco Bank Corp NY
TRST
$978M
| $937K | ﹤0.01% |
24,148
+2,360
| +11% | +$93.4K |
|
|
HES
2600
DELISTED
Hess
HES
| $935K | ﹤0.01% |
15,520
-64,747
| -81% | -$3.56M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.